From July 2020 to September 2023, Kevin served as CEO of Aldevron, a privately held genomics company that was acquired by Danaher Corporation in August 2021. Prior to joining Aldevron, Kevin spent 25 years at Boston Scientific Corporation. During his last nine years at Boston Scientific, Kevin served as Executive Vice President and Global President of the Interventional Cardiology division.

Kevin has served as a member of the Board of Directors of Silk Road Medical, a publicly traded company focused on reducing the risk of stroke, since December 2020. Kevin also served on the Board of Directors of Shockwave Medical, Inc., from June 2023 until its acquisition by Johnson & Johnson in May 2024.

Regina Benjamin, MD, MBA is the Founder and CEO of Bayou Clinic, and was the 18th United States Surgeon General (2009-2013).

As U.S. Surgeon General, Dr. Benjamin oversaw the operational command of 6,500 uniformed public health officers who serve in locations around the world to promote and protect the health of the American People. As chair of the National Prevention Council – 17 cabinet-level Federal Agency Heads, she led the development of the National Prevention Strategy: America’s Plan for Better Health and Wellness.

In 1995, she was the first physician under the age of 40 and the first African-American woman to be elected to the American Medical Association Board of Trustees. Other past board memberships included the Robert Wood Johnson Foundation, Kaiser Family Foundation Commission on Medicaid and the Uninsured, Catholic Health Association, and Morehouse School of Medicine.

She currently serves on the boards of Kaiser Hospitals and Health Plan; Ascension Health Alliance; ConvaTec PLC; Computer Technology Systems Inc (CPSI); and the American Heart Association.

Dr. Benjamin is a member of the Institute of Medicine and a Fellow of the American Academy of Family Physicians.

In 1998 Dr. Benjamin was the United States recipient of the Nelson Mandela Award for Health and Human Rights. She received the 2000 National Caring Award, which was inspired by Mother Teresa and was recognized with the Papal honor Pro Ecclesia et Ponticifice from Pope Benedict XVI. In 2008, she was honored with a MacArthur Genius Award Fellowship. In 2011, Dr. Benjamin became the recipient of the Chairman’s Award at the 42nd NAACP Image Awards. In May 2013, Reader’s Digest, ranked her #22 of the “100 Most Trusted People in America”.

Nadav brings 23 years of global, multi-segment general management experience in Medtech.

Nadav is the CEO of Cynosure Lutronic an energy based aesthetics device maker and lead the acquisition and merger with Lutronic announced in January, 2024.

Prior to Cynosure Lutronic Nadav was with Johnson & Johnson for 22 years where he last served as Global President, Spine for DePuy Synthes Companies. Additional roles at J&J include Vice President, for in the Diabetes Care franchise, including commercial activity for LifeScan and Animas subsidiaries as well as Vice President, Sales & Marketing, for the cardiovascular franchise including Cordis & Biosense Webster.

Nadav serves as a director for a Revival portfolio company, Augmedics, and leads Revival’s Israeli relations and strategy.

Martin spent over 30 years at McKinsey & Company where he led the global life sciences practice for 7 years ( 2014-2021) and co-founded/ co-led the McKinsey health institute (a non-profit generating initiative focused on extending healthspan).

Martin served clients across medical devices, biopharma and consumer health in North America, Europe, Asia and Middle East and South Africa. Earlier in his McKinsey career, he led the cross-industry organization practice in EMEA.

In addition to his board role at Distalmotion, Martin is also chair of the advisory board at Medgenome.

Sholmi has over 25 years of experience in the medical device industry and is currently serving as board member on multiple companies in the medical device industry as well as a board member at the Arnold and Mable Beckman Foundation, a foundation focused on supporting research in chemistry and life sciences.

Previously, Shlomi held senior operating roles at Johnson & Johnson, where he was the Company Group Chairman of Cardiovascular and Specialty Solutions and Visions Group within the Medical Devices sector. He was a member of the Medical Devices Group Operating Committee and lead a diverse portfolio of six diverse medical device businesses including Electrophysiology, Neurovascular Intervention, Ear, Nose & Throat, Breast Aesthetics, Optometry and Ophthalmology. Prior to that, Nachman had various roles with increase scope and responsibilities including Worldwide President of Biosense Webster and Cordis.

Manisha has held leadership positions in the intersection of healthcare and technology. As the Chief Growth Officer at Commure, Manisha was responsible for the sales, marketing, customer success, operations, and partnerships organizations. Prior to Commure, she was the Chief Operating Officer at Clarify Health Solutions, a technology company focused on analytical software solutions for payers, providers, and life sciences customers.

Prior to Manisha’s operating roles, she was a Partner at McKinsey & Company in the medical products, life sciences, and health systems/payor practices in the US, UK, and emerging markets. Her focus at McKinsey for over a decade was commercial growth and innovation with impact, including the use of technology and data to drive outcomes at improved cost for the health ecosystem.

Manisha has also worked in global health and healthcare investing at Acumen, the UNDP in Ethiopia, and the American India Foundation.

Manisha currently serves as a member of the Board of Directors for Model N, a public company that focuses on revenue lifecycle management software for life sciences companies, and as Chair of the Board of Directors at ReSurge International, a nonprofit humanitarian aid organization providing reconstructive surgical care in low-income countries worldwide.

Glen is currently CEO of EBI Bone Healing & Board member of HIGHRIDGE Medical, previously, the spine division of ZimVie.

Prior to Highridge Medical, Glen was the CEO of Cerapedics Inc., a privately held Ortho-biologics company focused on developing and commercializing peptide-enhanced bone graft products.

Glen has also served as Worldwide President for Spine & Bone Healing Technologies, Inc., a division of Biomet Inc. Additionally, Glen concurrently served as Senior Vice President on Biomet’s Worldwide Operating Board, encompassing the Orthopedics, Spine, Trauma, Biologics, and Sports Medicine businesses. Previously, he has held a number of Divisional president roles at Johnson & Johnson where he served as Worldwide President for Cordis Endovascular and Neurovascular and as Worldwide President for Codman Neuro Sciences and U.S. President of DePuy Spine.

In addition to his corporate roles, Glen has concurrently managed a contract manufacturing business, Ortho-Craft that was acquired by Paragon Medical in 2005. He has also served several board of director positions including SpineView, Palyon Medical, Veniti

Tiffanie has spent over 13 years as the Founder and Managing Principal of her own consulting company where she leverages her broad experiences to assist multinational, and early-stage startups, as well as large Fortune 500 companies, plan and execute strategies for clinical research and evidence generation, as well as for regulatory, product development, commercial, and market access & reimbursement.

Most recently, Tiffanie was the Vice President of Clinical & Medical Affairs at Apollo Endosurgery, where she was part of the executive leadership team when Apollo achieved FDA De Novo Market Authorization of the Apollo ESG, ESG Sx, Apollo REVISE and REVISE Sx System and Breakthrough Device Designation and PMA Approval for the Orbera Intragastric Balloon. Tiffanie was part of the team that managed all global market access and reimbursement processes for Apollo Endosurgery, which eventually resulted in two new C-Codes and a positive coverage decision in the United Kingdom from NICE for Boston Scientific, post its acquisition of Apollo Endosurgery.

Tiffanie volunteers as a facilitator, coach, and judge for MedTech Innovator, a nonprofit, global competition and accelerator for medical device, digital health, and diagnostic companies. Earlier roles and experience include Director of Global Market Development with Covidien, as well as Marketing Manager, Senior Product Manager, and Product Manager with the Stryker Corporation.

Spencer was CEO and board member of Kaleo, Inc from 2006-2021. While at Kaleo, Spencer led the growth of the company from a three-person start-up to a business with five FDA approved drug-device combination products. In 2021 Kaleo was acquired by Marathon Asset Management for $310M, including milestones.

Spencer was also on the board of Avenu Medical which developed a percutaneous AV fistula catheter product for chronic kidney disease patients. Avenu was acquired in 2020 by Medtronic.

Before Spencer’s private company experience, he held senior executive level positions with Guidant / Boston Scientific in the Cardiac Rhythm Management division.

In 2013 Spencer was named by EY as an Entrepreneur of the Year.

Victor (Vic) Chance is the President of BVC Consulting which provides consulting services in productivity improvement, operations excellence, supply chain strategies, strategic procurement and execution support for the supply chain and procurement functions.

Previously Vic served as Vice President, External Operations and Supply Chain Chief Procurement Officer for the Medical Device & Diagnostics Sector of Johnson & Johnson. In those roles, Vic was responsible for the external supplier network along with all associated external supply performance improvement.

In addition, Vic was also World-wide Vice President of Operations at Cordis and Ortho-Clinical Diagnostics – both Johnson and Johnson subsidiaries at the time. While Vic was at Cordis, they received recognition for operations excellence by receiving the Shingo Prize for Manufacturing as well as being a two-time winner of Industry Week’s “America’s Best Plants” award (Juarez, MX and San German, PR).

Yann co-founded and led Cardiologs as the CEO from its formation in 2014 until 2021 when it was acquired by Phillips. Yann remained with Phillips as the General Manager until December 2022.

Cardiologs is pioneering the development of AI applied to cardiovascular diagnostics at a global scale, to aid in the analysis of electrocardiograms (ECG’s). Cardiologs was one of the first products based on deep-learning to obtain regulatory clearances – both CE Mark in 2016 from the FDA in 2017 - and was used to diagnose 2 million patients in 2022.